LIN Linde plc
LIN Linde plc
Basic Materials · Specialty Chemicals
Desk view
Market read
Scan convergence 1 scan as of 2026-10-16 1 neutral converging
POC $491.38 · VWAP $471.49 · +5.7% vs 12m avg buyer
Insiders quiet 0 buy / 0 sell · Form 4, 90d
Coverage
LIN Price Structure
Loading timeframes…
Peers
Every watchlist LIN belongs to, members best 30-day change first — LIN highlighted in place. Each pill: 30d change, 1d/7d, and a close spark over the last 30 calendar days (~21 sessions); hover for price, RSI, and the full chart.
@thebuildout-specialty-electronic-gases
@thebuildout-specialty-gases-process-chemicals
@chemicals
@thebuildout-fuel-cells-alternative-dc-power
@escalation
@electricity
@ai-bottlenecks
Reported the quarter ending 2026-06-30: revenue $9.29B, diluted EPS $4.15, net income $1.93B attributable to the company (SEC 10-Q; revenue and EPS agree with it).
full note →Against street estimates
How LIN's reported EPS compared with analyst consensus. Street estimates are single-source vendor consensus (yfinance). Actuals are vendor consensus-basis EPS (often non-GAAP); edgarEps is GAAP diluted from filings — disputed flags large disagreement only. EPS only.
LIN research tape
35 dated scans, research, and events, newest first — the full record. Desk commentary and scheduled prints sit in their own panes.